Literature DB >> 10931128

TAP deficiency syndrome.

S D Gadola1, H T Moins-Teisserenc, J Trowsdale, W L Gross, V Cerundolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10931128      PMCID： PMC1905688          DOI： 10.1046/j.1365-2249.2000.01264.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  46 in total

1.  Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression.

Authors:  J Zimmer; L Donato; D Hanau; J P Cazenave; A Moretta; M M Tongio; H de la Salle
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

2.  Association of class I major histocompatibility heavy and light chains induced by viral peptides.

Authors:  A Townsend; C Ohlén; J Bastin; H G Ljunggren; L Foster; K Kärre
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

Review 3.  Control of infections by NK cells.

Authors:  C H Tay; E Szomolanyi-Tsuda; R M Welsh
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

4.  Positive selection of antigen-specific T cells in thymus by restricting MHC molecules.

Authors:  P Kisielow; H S Teh; H Blüthmann; H von Boehmer
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

5.  Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens.

Authors:  J L Touraine; H Betuel; G Souillet; M Jeune
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

Review 6.  Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors.

Authors:  M Colonna
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

7.  Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis.

Authors:  L Donato; H de la Salle; D Hanau; M M Tongio; M Oswald; A Vandevenne; J Geisert
Journal:  J Pediatr       Date:  1995-12       Impact factor: 4.406

8.  Chronic granulomatous disease in adults.

Authors:  J G Liese; V Jendrossek; A Jansson; T Petropoulou; S Kloos; M Gahr; B H Belohradsky
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

9.  A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules.

Authors:  N A Morrice; S J Powis
Journal:  Curr Biol       Date:  1998-06-04       Impact factor: 10.834

10.  Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis.

Authors:  S M Behar; C C Dascher; M J Grusby; C R Wang; M B Brenner
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307
View more
  41 in total

1.  Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway.

Authors:  Sheng Xu; Xingguang Liu; Yan Bao; Xuhui Zhu; Chaofeng Han; Peng Zhang; Xuemin Zhang; Weihua Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2012-04-22       Impact factor: 25.606

Review 2.  Immunity to microbes: lessons from primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Antonio Coutinho
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

Review 3.  [Genetic causes of impaired wound healing. Rare differential diagnosis of the non-healing wound].

Authors:  K Elsharkawi-Welt; J Hepp; K Scharffetter-Kochanek
Journal:  Hautarzt       Date:  2008-11       Impact factor: 0.751

Review 4.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

5.  Single nucleotide polymorphisms in the FcγR3A and TAP1 genes impact ADCC in cynomolgus monkey PBMCs.

Authors:  Jonathan C Sanford; Hong Wu; Yasmina Abdiche; Julie A Harney; Javier Chaparro-Riggers; Karissa Adkins
Journal:  Immunogenetics       Date:  2017-02-03       Impact factor: 2.846

6.  Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency.

Authors:  A Parissiadis; A Dormoy; D Fricker; D Hanau; H de la Salle; J-P Cazenave; P Lenoble; L Donato
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

Review 7.  Generation of MHC class I ligands in the secretory and vesicular pathways.

Authors:  Margarita Del Val; Salvador Iborra; Manuel Ramos; Silvia Lázaro
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

Review 8.  Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine.

Authors:  Eden Avishai; Kristina Yeghiazaryan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

9.  [Adult-onset primary immunodeficiencies].

Authors:  S Gadola; U Salzer; H Schultz; B Grimbacher
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

10.  TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss.

Authors:  Marco Caversaccio; Harald Marcel Bonél; Rachel Carter; Anthony P Williams; Stephan D Gadola
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-19       Impact factor: 2.503
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.